Kim, Jung Han <br/><br/>
Phase I/II study of immunotherapy using autologous tumor lysate-pulsed dendritic cells in patients with metastatic renal cell carcinoma.  [electronic resource] 

 -  Clinical immunology (Orlando, Fla.)  Dec 2007 
 - 257-67 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-6616 
<br/><br/><label>Standard No.: </label>10.1016/j.clim.2007.07.014  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antigens, Neoplasm<br/>Carcinoma, Renal Cell--immunology<br/>Cytokines--blood<br/>Dendritic Cells--transplantation<br/>Enzyme-Linked Immunosorbent Assay<br/>Female<br/>Hemocyanins<br/>Humans<br/>Hypersensitivity, Delayed<br/>Immunotherapy, Adoptive<br/>Interferon-gamma--biosynthesis<br/>Kidney Neoplasms--immunology<br/>Male<br/>Middle Aged<br/>Transplantation, Autologous